Atlas Trials

Inventprise Inc.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Inventprise Inc.

RecordFirmDate
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults (NCT07205926)Inventprise Inc.2025-10-09
Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants (NCT06790290)Inventprise Inc.2025-01-27
Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. (NCT06611371)Inventprise Inc.2024-11-12
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine (NCT06077656)Inventprise Inc.2023-10-25
Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine (NCT05540028)Inventprise Inc.2022-09-28

Track Inventprise Inc. automatically

Every clearance here is in the API, with alerts when new ones post.